What is Bioperfectus diagnostic strategy under new SARS-CoV-2 variants?

Company news
2021-06-23

On May 31st, WHO announced simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern. Since the outbreak of SARS-CoV-2, genetic variants of SARS-CoV-2 have been emerging and circulating globally. These variants can be very transmissible and have potential to increase hospitalizations and fatality rates.

In face of SARS-CoV-2 variants, what is our diagnostic strategy?

 

Bioperfectus, as a pioneering infectious disease diagnostic solution provider in the globe, has been studying the characteristics of the SARS-CoV-2 variants and working on developing most effective, efficient and accessible diagnostic solutions to combat COVID-19 pandemic.

 

Under the investigation of Bioperfectus R&D team, we hereby conclude that Bioperfectus COVID-19 Coronavirus Real Time PCR Kit, COVID-19 Coronavirus (ORF1ab/N/E) Real Time PCR Kit and COVID-19 Coronavirus and Influenza A/B Virus Real Time PCR Kit are confirmed to stay effective and free from the impact of the listed SARS-CoV-2 variants below:

 

 

Reference: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

MOST READ

Empowering Women's Health: Gynecologic Cancer Awareness Month

September is Gynecologic Cancer Awareness Month! Join us in raising awareness this month.

2023-09-21

Academy Express | Human Papillomavirus (HPV) Infection and Its Impact on Male Infertility

HPV semen infection, regardless of HPV type and exact location of the virions, significantly impairs spermatozoa’s progressive motility, morphology, and immotile sperm rate.

2023-09-07

World Sexual Health Day 2023: Empowering Sexual Well-being

Today serves as a reminder to prioritize sexual health and foster positive attitudes toward consent.

2023-09-04